Is Europe still worth it for Medtech Companies? | Oliver Bisazza | Medtech Europe
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Is Europe still worth it for Medtech Companies? | Oliver Bisazza | Medtech Europe
-
Letto da:
-
Di:
A proposito di questo titolo
Oliver Bisazza is the CEO of MedTech Europe.
With a background in EU policy and regulatory leadership, Oliver has played a key role in shaping Europe’s medtech landscape, now focused on strengthening competitiveness, advancing regulation, and improving patient access to innovation.
Oliver has watched this industry from the inside for nearly 20 years. He's lived through the MDR chaos, the pandemic, the talent drought, and the moment European politicians finally started asking what do we need to do to keep you here?
In this episode, Oliver Bisazza joins us to discuss “Is Europe still worth it for medtech companies?” We talk about how Europe’s medtech landscape is evolving, and why staying competitive globally is no longer guaranteed.
Tune in for:
- Why Europe’s attractiveness for medtech companies should not be taken for granted
- How sustainability can be a competitive edge.
- How to cut through “noise” and say no to the right things.
- What MDR & IVDR really taught the industry about public trust.
- How talent gaps and digital transformation are reshaping medtech.
Career inspiration, medtech opportunities, hiring solutions and market insights, all in one place. Find them here.